MedTrace Logo

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

NCT02944461 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-04-03

Study results available
· View outcomes & findings →

Summary

To determine if Dapsone (Aczone) 7.5% gel is a safe and effective treatment for acne on the trunk

Conditions

Interventions

DRUG

Dapsone 7.5 % gel

Dapsone gel 7.5% applied once daily to truncal acne

Sponsors & Collaborators

  • Derm Research, PLLC

    lead OTHER

Principal Investigators

  • Leon H. Kircik, M.D. · DermResearch PLLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-09-30
Completion
2017-09-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02944461 on ClinicalTrials.gov